Blueprint Medicines: Multibillion-Dollar Opportunity Through Innovative Cancer Drugs

In particular, biopharmaceuticals targeting rare and difficult-to-treat diseases are of great importance for patients because there are generally few or no effective therapies available for them. Targeted therapies, such as those from Blueprint Medicines that focus on specific genetic or molecular changes, bring attractive growth potential. Thanks to their high precision, these drugs are often more effective than conventional treatment approaches like chemotherapy. This leads to a high and increasing demand, which has recently had a direct impact...